{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T09:43:44Z","timestamp":1717062224606},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,9,1]]},"DOI":"10.1093\/alcalc\/agh171","type":"journal-article","created":{"date-parts":[[2005,6,6]],"date-time":"2005-06-06T20:12:53Z","timestamp":1118088773000},"page":"422-430","source":"Crossref","is-referenced-by-count":13,"title":["A CRITICAL REVIEW OF PHARMACOECONOMIC STUDIES OF ACAMPROSATE"],"prefix":"10.1093","volume":"40","author":[{"given":"FLAVIO","family":"POLDRUGO","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DORIS-ANITA","family":"HAEGER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SYLVIE","family":"COMTE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JAN","family":"WALBURG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ANDREW J.","family":"PALMER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2005,6,6]]},"reference":[{"key":"key\n\t\t\t\t20171011014059_B1","doi-asserted-by":"crossref","unstructured":"Annemans, L., Vanoverbeke, N., Tecco, J. et al. (2000) Economic evaluation of Campral (Acamprosate) compared to placebo in maintaining abstinence in alcohol-dependent patients. European Addiction Research6, 71\u201378.","DOI":"10.1159\/000019013"},{"key":"key\n\t\t\t\t20171011014059_B2","doi-asserted-by":"crossref","unstructured":"Briggs, A. and Sculpher, M. (1998) An introduction to Markov modelling for economic evaluation. Pharmacoeconomics13, 397\u2013409.","DOI":"10.2165\/00019053-199813040-00003"},{"key":"key\n\t\t\t\t20171011014059_B3","doi-asserted-by":"crossref","unstructured":"Chick J., Lehert P. and Landron, F. (2003) Does acamprosate improve reduction of drinking as well as aiding abstinence? Journal of Psychopharmacology17, 397\u2013402.","DOI":"10.1177\/0269881103174017"},{"key":"key\n\t\t\t\t20171011014059_B4","unstructured":"Chick, J., Rund, D. and Gilbert, M. A. (1991) Orthopaedic trauma in men: the relative risk among drinkers and the prevalence of problem drinking in male orthopaedic admissions. Annals of the Royal College of Surgeons England73, 311\u2013314."},{"key":"key\n\t\t\t\t20171011014059_B5","doi-asserted-by":"crossref","unstructured":"COMBINE Study Research Group (2003) Testing combined pharmacotherapies and behavioral interventions in alcohol dependence: rationale and methods. Alcoholism: Clinical and Experimental Research27, 1107\u20131122.","DOI":"10.1111\/j.1530-0277.2003.tb02873.x"},{"key":"key\n\t\t\t\t20171011014059_B6","doi-asserted-by":"crossref","unstructured":"Finney, J. W. and Monahan, S. C. (1996) The cost-effectiveness of treatment for alcoholism: a second approximation. Journal of Studies on Alcohol57, 229\u2013243.","DOI":"10.15288\/jsa.1996.57.229"},{"key":"key\n\t\t\t\t20171011014059_B7","doi-asserted-by":"crossref","unstructured":"Gual, A. and Lehert, P. (2001) Acamprosate during and after acute alcohol withdrawal: a double-blind placebo-controlled study in Spain. Alcohol and Alcoholism36, 413\u2013418.","DOI":"10.1093\/alcalc\/36.5.413"},{"key":"key\n\t\t\t\t20171011014059_B8","unstructured":"Hein, R. and Salomaa, J. (1999) What are the costs of substance abuse? Alcohol and drugs. Alcologia11, 135\u2013143."},{"key":"key\n\t\t\t\t20171011014059_B9","doi-asserted-by":"crossref","unstructured":"Holder, H. D. (1987) Alcoholism treatment and potential health cost saving. Medical Care25, 52\u201371.","DOI":"10.1097\/00005650-198701000-00007"},{"key":"key\n\t\t\t\t20171011014059_B10","doi-asserted-by":"crossref","unstructured":"Holder, H. D. and Blose, J. O. (1991) Typical patterns and cost of alcoholism treatment across a variety of populations and providers. Alcoholism: Clinical and Experimental Research15, 190\u2013195.","DOI":"10.1111\/j.1530-0277.1991.tb01854.x"},{"key":"key\n\t\t\t\t20171011014059_B11","doi-asserted-by":"crossref","unstructured":"Holder, H. D. and Blose, J. O. (1992) The reduction of health care costs associated with alcoholism treatment: a 14-year longitudinal study. Journal of Studies on Alcohol53, 293\u2013302.","DOI":"10.15288\/jsa.1992.53.293"},{"key":"key\n\t\t\t\t20171011014059_B12","doi-asserted-by":"crossref","unstructured":"Holder, H. D., Cisler, R. A., Longabaugh, R. et al. (2000) Alcoholism treatment and medical care costs from Project MATCH. Addiction95, 999\u20131013.","DOI":"10.1046\/j.1360-0443.2000.9579993.x"},{"key":"key\n\t\t\t\t20171011014059_B13","doi-asserted-by":"crossref","unstructured":"Holder, H. D. and Hallan, J.B. (1986) Impact of alcoholism treatment on total health care costs: a six year study. Advances in Alcohol and Substance Abuse6, 1\u201315.","DOI":"10.1300\/J251v06n01_01"},{"key":"key\n\t\t\t\t20171011014059_B14","doi-asserted-by":"crossref","unstructured":"Holder, H. D., Longabaugh, R., Miller, W. R. et al. (1991) The cost effectiveness of treatment for alcoholism: a first approximation. Journal of Studies on Alcohol52, 517\u2013540.","DOI":"10.15288\/jsa.1991.52.517"},{"key":"key\n\t\t\t\t20171011014059_B15","doi-asserted-by":"crossref","unstructured":"Kiritz\u00e9-Topor, P., Huas, D., Rosenzweig, C. et al. (2004) A pragmatic trial of acamprosate in the treatment of alcohol dependence in primary care. Alcohol and Alcoholism, in press.","DOI":"10.1093\/alcalc\/agh088"},{"key":"key\n\t\t\t\t20171011014059_B16","doi-asserted-by":"crossref","unstructured":"Mann, K., Lehert, P. and Morgan, M. Y. (2004) The efficacy of acamprosate in the maintenance of abstinence in alcohol-dependent individuals: results of a meta-analysis. Alcoholism: Clinical and Experimental Research28, 51\u201363.","DOI":"10.1097\/01.ALC.0000108656.81563.05"},{"key":"key\n\t\t\t\t20171011014059_B17","doi-asserted-by":"crossref","unstructured":"Mann, K. (2004) Pharmacotherapy of alcohol dependence: a review of the clinical data. CNS Drugs18, 485\u2013504.","DOI":"10.2165\/00023210-200418080-00002"},{"key":"key\n\t\t\t\t20171011014059_B18","unstructured":"Mason, B. J. (2001) Results of the multicenter study of acamprosate in the treatment of alcoholism. Biological Psychiatry48 (Suppl. 8), 77S (abstract)."},{"key":"key\n\t\t\t\t20171011014059_B19","doi-asserted-by":"crossref","unstructured":"McKenna, M., Chick, J., Buxton, M. et al. (1996) The SECCAT survey: 1. The costs and consequences of alcoholism. Alcohol and Alcoholism31, 565\u2013576.","DOI":"10.1093\/oxfordjournals.alcalc.a008192"},{"key":"key\n\t\t\t\t20171011014059_B20","doi-asserted-by":"crossref","unstructured":"Morgan, M. Y., Landron F. and Lehert, P. (2004). Improvement in quality of life after treatment for alcohol dependence with acamprosate and psychosocial support. Alcoholism: Clinical and Experimental Research28, 64\u201377.","DOI":"10.1097\/01.ALC.0000108652.73143.4B"},{"key":"key\n\t\t\t\t20171011014059_B21","doi-asserted-by":"crossref","unstructured":"Palmer, A. J., Neeser, K., Weiss, C. et al. (2000) The long-term cost effectiveness of improving alcohol abstinence with adjuvant acamprosate. Alcohol and Alcoholism35, 478\u2013492.","DOI":"10.1093\/alcalc\/35.5.478"},{"key":"key\n\t\t\t\t20171011014059_B22","doi-asserted-by":"crossref","unstructured":"Patience, D., Buxton, M., Chick, J. et al. (1997) The SECCAT survey: II. The alcohol-related problems questionnaire as a proxy for resource costs and quality of life in alcoholism treatment. Alcohol and Alcoholism32, 79\u201384.","DOI":"10.1093\/oxfordjournals.alcalc.a008237"},{"key":"key\n\t\t\t\t20171011014059_B23","doi-asserted-by":"crossref","unstructured":"Pelc, I., Ansoms, C., Lehert, P. et al. (2002) The European NEAT program: an integrated approach using acamprosate and psychosocial support for the prevention of relapse in alcohol-dependent patients with a statistical modeling of therapy success prediction. Alcoholism: Clinical and Experimental Research26, 1529\u20131538.","DOI":"10.1111\/j.1530-0277.2002.tb02452.x"},{"key":"key\n\t\t\t\t20171011014059_B24","unstructured":"Portella, E., Ridao, M., Carrillo, E. et al. (1998) El alcohol y su abuso: impacto socioecon\u00f3mico. Editorial M\u00e9dica Panamericana, Madrid."},{"key":"key\n\t\t\t\t20171011014059_B25","doi-asserted-by":"crossref","unstructured":"Reynaud, M., Gaudin-Colombel, A. F. and Le Pen, C. (2001) Two methods of estimating health costs linked to alcoholism in France (with a note on social costs). Alcohol and Alcoholism36, 89\u201395.","DOI":"10.1093\/alcalc\/36.1.89"},{"key":"key\n\t\t\t\t20171011014059_B26","doi-asserted-by":"crossref","unstructured":"Rychlik, R., Siedentop, H., Pfeil, T. et al. (2001) Cost-effectiveness of adjuvant treatment with acamprosate in maintaining abstinence in alcohol dependent patients. European Addiction Research9, 59\u201364.","DOI":"10.1159\/000068810"},{"key":"key\n\t\t\t\t20171011014059_B27","doi-asserted-by":"crossref","unstructured":"Sass, H., Soyka, M., Mann, K. et al. (1996) Relapse prevention by acamprosate: results from a placebo controlled study in alcohol dependence. Archives of General Psychiatry53, 673\u2013680.","DOI":"10.1001\/archpsyc.1996.01830080023006"},{"key":"key\n\t\t\t\t20171011014059_B28","doi-asserted-by":"crossref","unstructured":"Sch\u00e4dlich, P. K. and Brecht, J. G. (1998) The cost effectiveness of acamprosate in the treatment of alcoholism: economic evaluation of the Prevention of Relapse with Acamprosate in Management of Alcoholism (PRAMA) Study. Pharmacoeconomics13, 719\u2013730.","DOI":"10.2165\/00019053-199813060-00008"},{"key":"key\n\t\t\t\t20171011014059_B29","doi-asserted-by":"crossref","unstructured":"Whitworth, A. B., Fischer, F., Lesch, O. M. et al. (1996) Comparison of acamprosate and placebo in long-term treatment of alcohol dependence. Lancet347, 1438\u20131442.","DOI":"10.1016\/S0140-6736(96)91682-7"},{"key":"key\n\t\t\t\t20171011014059_B30","doi-asserted-by":"crossref","unstructured":"Zook, C. J. and Moore, F. D. (1980) High cost users of medical care. The New England Journal of Medicine302, 996\u20131002.","DOI":"10.1056\/NEJM198005013021804"}],"container-title":["Alcohol and Alcoholism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/alcalc\/article-pdf\/40\/5\/422\/463581\/agh171.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,23]],"date-time":"2019-02-23T05:15:05Z","timestamp":1550898905000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/alcalc\/article\/40\/5\/422\/188402\/A-CRITICAL-REVIEW-OF-PHARMACOECONOMIC-STUDIES-OF"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6,6]]},"references-count":30,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2005,6,6]]},"published-print":{"date-parts":[[2005,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/alcalc\/agh171","relation":{},"ISSN":["1464-3502","0735-0414"],"issn-type":[{"value":"1464-3502","type":"electronic"},{"value":"0735-0414","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,9]]},"published":{"date-parts":[[2005,6,6]]}}}